Anti-HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1109

Alias

科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab

Molecular Name

Efungumab

Size

1mg, 5mg

CAS Number

762260-74-2

Isotype

scFv-heavy Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

FC, IP, ELISA, Neut, FuncS, IF, WB

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

HSP91 homolog[Candida albicans]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ